MiRNA-146a/AKT/β-Catenin Activation Regulates Cancer Stem Cell Phenotype in Oral Squamous Cell Carcinoma by Targeting CD24. This evidence concerns the gene AKT1 and oral cavity squamous cell carcinoma.